GC is distinguished by the Lauren classification (intestinal, diffuse, and mixed types) and is frequently associated with mutations in genes such as tumor protein p53 (TP53), low-density lipoprotein receptor-related protein 1B (LRP1B), and AT-rich interaction domain 1A (ARID1A) (66). This evidence concerns the gene ARID1A and gastric cancer.